【摘要】 目的 :探讨康莱特注射液联合化疗对晚期癌症的临床疗效。方法 :将64例晚期癌症患者作为观察组 ,接受康莱特与化疗联合治疗 ;47例晚期癌症患者作为对照组 ,接受常规化疗。结果 :观察组有效率48 44 % ,体重增加57 81 % ,卡氏评分提高85 93 % ,疼痛减轻71 87 % ;对照组有效率34 04 % ,体重增加22 66 % ,卡氏评分提高48 93 % ,疼痛减轻46 81 %。化疗毒副反应显示 ,观察组明显低于对照组。结论 :康莱特联合化疗对晚期癌症患者提高疗效、改善生活质量效果显著。更多还原

【Abstract】 OBJECTIVE:To observe the clinical therapeutic effect of KLT combined with chemotherapy on late canˉcers.METHODS:64patients with late cancers were assigned as observation group:receiving KLT+chemotherapy;47patients with late cancers were assigned as control group:receiving routine chemotherapy.RESULTS:In the observation group,the efˉfective rate was48.44%,body weight increase accounted for57.81%,KSP increased85.93%and relief from pain accounted for71.87%;In the control group:the effective rate was34.04%,body weight increase accounted for22.66%,KSD increased48.93%and relief from pain accounted for46.81%.The incidence of ARDs in observation group was obviouly lower than those in control group.CONCLUSION:KLT combined with chemotherapy can raise the therapeut effect on patients with late cancers and improve their life quality.更多还原